Italy

Key activities:

Blood & Beyond in Italy aims to:
Consolidate efficiency of Italy’s blood management system and extend patients’ benefit through therapeutic and organizational innovation.
There is an opportunity to highlight the Blood & Beyond initiative during the World Blood Donor Day 2021, hosted in Italy with a multi-panel stakeholder workshop and a virtual booth.

“Rethink blood use” workshop moderated by Tamsin Rose.
Confirmed Speakers: Dr Esther Natalie Oliva (Department of Haematology, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli di Reggio Calabria; Reggio Calabria, Italy, and Board Member, European Haematology Association Scientific Working Group on Quality of Life), Dr Androulla Eleftheriou – (Executive Director, Thalassaemia International Federation, Strovolos, Cyprus) and Dr. Della Porta (Associate Professor Medical Oncology– Haematology Oncology Department – Fondazione IRCCS Policlinico San Matteo and Pavia University AIPASIM – Scientific Board) Dr.ssa Alice Simonetti (AVIS – Delegate for European policies)

You can access the event recording here.

Achievements:

Regional multi-stakeholder events have been carried out through Italy in 2021 to enhance awareness on how innovation can improve blood management and address both chronic transfusion burden and blood availability for emergency purposes
Celgene, now part of Bristol Myers Squibb, is sponsoring in Italy the “Magnifico Donare” campaign – a multi-city multi-year campaign promoted by MDs association (AiPASiM) and Beta-thalassemia association (United) in partnership with Avis (donors’ association) to encourage the younger population to donate blood, highlighting its importance for transfusion dependent patients

Contact person:

https://www.bms.com/it

Stay up to date

    © CSL 2026

    Blood & Beyond is a multi-stakeholder initiative funded by CSL, involving experts from the fields of haematology, transfusion medicine, anaesthesiology, patient blood management, nursing, patient advocacy, health economics, and hospital management, with support from policymakers committed to driving improvements in this area. The aim of the initiative is to raise awareness of the importance of good blood health and of the impact of anaemia on patients, healthcare systems and society at large, with the overarching goal to help advance policies and practices that improve patient outcomes by supporting patient-centricity in anaemia prevention, diagnosis, and management through patient blood management (PBM) and innovation.

    Contact

    For further information and queries, please contact the Blood and Beyond Secretariat: javier.lopezpanos@dgagroup.com

    Privacy Preference Center